Stigma Grow

Data Snapshot: Jul 04, 2024
Stigma Grow Cannabis Brand Logo
$100K+

Jun-2024

Sales

Decline

Trend

6-Month

14

Product Count

SKUs

Stigma Grow

Overview

Stigma Grow is a pioneering Alberta-based company, specializing in the cultivation of top-tier cannabis and the extraction of high-terpene cannabis extracts. As a wholly owned subsidiary of the Canadian cannabis company, CanadaBis Capital, it strives to offer consumers highly potent and quality-driven cannabis products. Recognised in the "Green Rush" of the cannabis industry, Stigma Grow stands out for its innovative approach to cannabis cultivation and extraction techniques, highlighting a global future perspective on cannabis as a potentially mainstream pain medicine.
Markets

Stigma Grow Locations

Product Trends

Stigma Grow Categories

Stigma Grow Sales

Market Insights Snapshot

Stigma Grow Historical Sales by Category

Stigma Grow has shown a strong performance in the Capsules category across various provinces, particularly in Alberta. In Alberta, they maintained the top position from March to May 2024 before slipping to second place in June 2024. Despite this slight drop, their sales figures demonstrate a consistent demand, even though there was a noticeable decline from March to June. In British Columbia, Stigma Grow has fluctuated in the Capsules category, ranking sixth in March, dropping to ninth in April and May, and slightly improving to seventh in June. This indicates a competitive market in British Columbia where Stigma Grow is holding its ground but faces stiff competition. Meanwhile, in Ontario, the brand has maintained a steady ninth position throughout the months, reflecting a stable yet unremarkable presence in that market.

The performance in the Concentrates category presents a more varied picture. In Alberta, Stigma Grow has seen some positive movement, improving from the 16th position in March to 15th in April, then slipping back to 17th in May, but recovering to 15th again in June. This fluctuation suggests a volatile market where Stigma Grow is striving to improve its standing. Conversely, in British Columbia, the brand has shown a positive trend, moving from 26th place in March to 18th in April, and maintaining a position within the top 20 through June. However, the fact that Stigma Grow did not rank in the top 30 in some months in certain categories indicates areas where the brand could potentially focus on improving its market penetration and competitive strategy.

Jun-2024 Rank
Capsules
Concentrates
2
15
7
19
9
Stigma Grow

Competitive Landscape

In the Alberta capsules category, Stigma Grow has shown a notable shift in its competitive positioning over recent months. Initially holding the top rank in March, April, and May 2024, Stigma Grow experienced a slight decline to the second position in June 2024. This change coincided with a consistent increase in sales for Glacial Gold, which rose to the first position in June. Meanwhile, Dosecann maintained a steady fourth position throughout the period, and Ovis showed a significant improvement, climbing from seventh in March to third in June. These shifts indicate a dynamic market where Stigma Grow faces increasing competition, particularly from Glacial Gold, which has shown strong upward momentum in both rank and sales.

Stigma Grow market ranking for AB Capsules

Stigma Grow

Notable Products

In June 2024, the top-performing product for Stigma Grow was Indica RSO Capsules 25-Pack (250mg) in the Capsules category, maintaining its number one rank consistently from March to June, with sales of 6,271 units. Phoenix Tears RSO (1g) in the Concentrates category also held steady in the second position throughout the same period, showing a notable increase in sales to 3,154 units. CBD Softgels 15-Pack (750mg CBD) in the Capsules category consistently ranked third from March to June, with a gradual increase in sales each month. The Ghost Train Haze Infused Pre-Roll (0.5g) debuted at rank four in May 2024 and maintained this position in June. Lastly, Phoenix Tears Honey Oil (1g), another Concentrates product, reappeared in the rankings at fifth place in June after not being ranked in April and May.

Product Rank
Category
Mar-2024
Apr-2024
May-2024
Jun-2024
Indica RSO Capsules 25-Pack (250mg)
Capsules
1
1
1
1
Phoenix Tears RSO (1g)
Concentrates
2
2
2
2
CBD Softgels 15-Pack (750mg CBD)
Capsules
3
3
3
3
Ghost Train Haze Infused Pre-Roll (0.5g)
Pre-Roll
>5
>5
4
4
Phoenix Tears Honey Oil (1g)
Concentrates
5
>5
>5
5
View product & sales data

Top Selling Cannabis Brands

Simple, transparent pricing that grows with you. Try any plan free for 30 days.
Research the top cannabis brands across markets in the US and Canada.
Header image
User rating
start Today
Connect to Headset

Get Cannabis Market Data